Performance of the 12-item WHODAS 2.0 in prodromal Huntington disease

Ji-In Kim; Jeffrey D Long; James A Mills; Nancy Downing; Janet K Williams; Jane S Paulsen; PREDICT-HD Investigators And Coordinators Of The Huntington Study Group; Zofia Helena Miedzybrodzka

doi:10.1038/ejhg.2015.11

Performance of the 12-item WHODAS 2.0 in prodromal Huntington disease

Ji-In Kim, Jeffrey D Long, James A Mills, Nancy Downing, Janet K Williams, Jane S Paulsen, PREDICT-HD Investigators And Coordinators Of The Huntington Study Group, Zofia Helena Miedzybrodzka

University of Iowa

Research output: Contribution to journal › Article › peer-review

13 Citations (Scopus)

11 Downloads (Pure)

Abstract

The Diagnostic and Statistical Manual for Mental Disorders, Fifth Edition (DSM-5), recommends the World Health Organization Disability Assessment Schedule (WHODAS) 2.0 for routine clinical use. We tested the utility of the 12-item WHODAS 2.0 in prodromal Huntington disease. Using data from 726 participants and 630 companions over a 3-year follow-up, linear mixed models were fitted to test (1) baseline and longitudinal differences by progression group; (2) participant and companion differences within each group; and (3) sensitivity of the 12-item WHODAS in comparison to the 36-item WHODAS and the Total Functional Capacity (TFC) score from the Unified Huntington's Disease Rating Scale. Participants showed baseline group differences whereas companions showed baseline and longitudinal group differences. Companions reported worse functional decline over time than participants as the disease progresses. The 12-item WHODAS detected longitudinal change better than the 36-item WHODAS and the TFC in the medium progression group. Results suggest the 12-item WHODAS 2.0 can detect baseline and longitudinal differences in prodromal HD and may be useful in HD clinical trials.

Original language	English
Pages (from-to)	1584-1587
Number of pages	4
Journal	EJHG : European journal of human genetics : the official journal of the European Society of Human Genetics.
Volume	23
Issue number	11
Early online date	4 Mar 2015
DOIs	https://doi.org/10.1038/ejhg.2015.11
Publication status	Published - 2015

Bibliographical note

ACKNOWLEDGEMENTS
We thank the PREDICT-HD sites, the study participants, the National Research
Roster for Huntington Disease Patients and Families, the Huntington’s Disease
Society of America and the Huntington Study Group. This publication was
supported by the National Center for Advancing Translational Sciences, and the
National Institutes of Health (NIH), through Grant 2 UL1 TR000442-06.
The content is solely the responsibility of the authors and does not necessarily
represent the official views of the NIH. This research is supported by the
National Institutes of Health, National Institute of Neurological Disorders and
Stroke (5R01NS040068) awarded to Dr Paulsen, CHDI Foundation, Inc
(A3917) awarded to Dr Paulsen, Cognitive and Functional Brain Changes in
Preclinical Huntington’s Disease (HD) (5R01NS054893) awarded to Dr
Paulsen, 4D Shape Analysis for Modeling Spatiotemporal Change Trajectories
in Huntington’s (1U01NS082086), Functional Connectivity in Premanifest
Huntington’s Disease (1U01NS082083), and Basal Ganglia Shape Analysis and
Circuitry in Huntington’s Disease (1U01NS082085).

Access to Document

10.1038/ejhg.2015.11Licence: CC BY-NC-ND

Performance of the 12-item WHODAS 2.0 in prodromal Huntington disease
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/.
Final published version, 1.42 MBLicence: CC BY-NC-ND

Cite this

Kim, J.-I., Long, J. D., Mills, J. A., Downing, N., Williams, J. K., Paulsen, J. S., PREDICT-HD Investigators And Coordinators Of The Huntington Study Group, & Miedzybrodzka, Z. H. (2015). Performance of the 12-item WHODAS 2.0 in prodromal Huntington disease. EJHG : European journal of human genetics : the official journal of the European Society of Human Genetics. , 23(11), 1584-1587. https://doi.org/10.1038/ejhg.2015.11

Kim, J-I, Long, JD, Mills, JA, Downing, N, Williams, JK, Paulsen, JS, PREDICT-HD Investigators And Coordinators Of The Huntington Study Group & Miedzybrodzka, ZH 2015, 'Performance of the 12-item WHODAS 2.0 in prodromal Huntington disease', EJHG : European journal of human genetics : the official journal of the European Society of Human Genetics. , vol. 23, no. 11, pp. 1584-1587. https://doi.org/10.1038/ejhg.2015.11

@article{f138c6a24dbb4924b60ddab0b5f92f18,

title = "Performance of the 12-item WHODAS 2.0 in prodromal Huntington disease",

abstract = "The Diagnostic and Statistical Manual for Mental Disorders, Fifth Edition (DSM-5), recommends the World Health Organization Disability Assessment Schedule (WHODAS) 2.0 for routine clinical use. We tested the utility of the 12-item WHODAS 2.0 in prodromal Huntington disease. Using data from 726 participants and 630 companions over a 3-year follow-up, linear mixed models were fitted to test (1) baseline and longitudinal differences by progression group; (2) participant and companion differences within each group; and (3) sensitivity of the 12-item WHODAS in comparison to the 36-item WHODAS and the Total Functional Capacity (TFC) score from the Unified Huntington's Disease Rating Scale. Participants showed baseline group differences whereas companions showed baseline and longitudinal group differences. Companions reported worse functional decline over time than participants as the disease progresses. The 12-item WHODAS detected longitudinal change better than the 36-item WHODAS and the TFC in the medium progression group. Results suggest the 12-item WHODAS 2.0 can detect baseline and longitudinal differences in prodromal HD and may be useful in HD clinical trials.",

author = "Ji-In Kim and Long, {Jeffrey D} and Mills, {James A} and Nancy Downing and Williams, {Janet K} and Paulsen, {Jane S} and {PREDICT-HD Investigators And Coordinators Of The Huntington Study Group} and Miedzybrodzka, {Zofia Helena}",

note = "ACKNOWLEDGEMENTS We thank the PREDICT-HD sites, the study participants, the National Research Roster for Huntington Disease Patients and Families, the Huntington{\textquoteright}s Disease Society of America and the Huntington Study Group. This publication was supported by the National Center for Advancing Translational Sciences, and the National Institutes of Health (NIH), through Grant 2 UL1 TR000442-06. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. This research is supported by the National Institutes of Health, National Institute of Neurological Disorders and Stroke (5R01NS040068) awarded to Dr Paulsen, CHDI Foundation, Inc (A3917) awarded to Dr Paulsen, Cognitive and Functional Brain Changes in Preclinical Huntington{\textquoteright}s Disease (HD) (5R01NS054893) awarded to Dr Paulsen, 4D Shape Analysis for Modeling Spatiotemporal Change Trajectories in Huntington{\textquoteright}s (1U01NS082086), Functional Connectivity in Premanifest Huntington{\textquoteright}s Disease (1U01NS082083), and Basal Ganglia Shape Analysis and Circuitry in Huntington{\textquoteright}s Disease (1U01NS082085).",

year = "2015",

doi = "10.1038/ejhg.2015.11",

language = "English",

volume = "23",

pages = "1584--1587",

journal = "EJHG : European journal of human genetics : the official journal of the European Society of Human Genetics. ",

issn = "1018-4813",

publisher = "Nature Publishing Group",

number = "11",

}

TY - JOUR

T1 - Performance of the 12-item WHODAS 2.0 in prodromal Huntington disease

AU - Kim, Ji-In

AU - Long, Jeffrey D

AU - Mills, James A

AU - Downing, Nancy

AU - Williams, Janet K

AU - Paulsen, Jane S

AU - PREDICT-HD Investigators And Coordinators Of The Huntington Study Group

AU - Miedzybrodzka, Zofia Helena

N1 - ACKNOWLEDGEMENTS We thank the PREDICT-HD sites, the study participants, the National Research Roster for Huntington Disease Patients and Families, the Huntington’s Disease Society of America and the Huntington Study Group. This publication was supported by the National Center for Advancing Translational Sciences, and the National Institutes of Health (NIH), through Grant 2 UL1 TR000442-06. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. This research is supported by the National Institutes of Health, National Institute of Neurological Disorders and Stroke (5R01NS040068) awarded to Dr Paulsen, CHDI Foundation, Inc (A3917) awarded to Dr Paulsen, Cognitive and Functional Brain Changes in Preclinical Huntington’s Disease (HD) (5R01NS054893) awarded to Dr Paulsen, 4D Shape Analysis for Modeling Spatiotemporal Change Trajectories in Huntington’s (1U01NS082086), Functional Connectivity in Premanifest Huntington’s Disease (1U01NS082083), and Basal Ganglia Shape Analysis and Circuitry in Huntington’s Disease (1U01NS082085).

PY - 2015

Y1 - 2015

N2 - The Diagnostic and Statistical Manual for Mental Disorders, Fifth Edition (DSM-5), recommends the World Health Organization Disability Assessment Schedule (WHODAS) 2.0 for routine clinical use. We tested the utility of the 12-item WHODAS 2.0 in prodromal Huntington disease. Using data from 726 participants and 630 companions over a 3-year follow-up, linear mixed models were fitted to test (1) baseline and longitudinal differences by progression group; (2) participant and companion differences within each group; and (3) sensitivity of the 12-item WHODAS in comparison to the 36-item WHODAS and the Total Functional Capacity (TFC) score from the Unified Huntington's Disease Rating Scale. Participants showed baseline group differences whereas companions showed baseline and longitudinal group differences. Companions reported worse functional decline over time than participants as the disease progresses. The 12-item WHODAS detected longitudinal change better than the 36-item WHODAS and the TFC in the medium progression group. Results suggest the 12-item WHODAS 2.0 can detect baseline and longitudinal differences in prodromal HD and may be useful in HD clinical trials.

AB - The Diagnostic and Statistical Manual for Mental Disorders, Fifth Edition (DSM-5), recommends the World Health Organization Disability Assessment Schedule (WHODAS) 2.0 for routine clinical use. We tested the utility of the 12-item WHODAS 2.0 in prodromal Huntington disease. Using data from 726 participants and 630 companions over a 3-year follow-up, linear mixed models were fitted to test (1) baseline and longitudinal differences by progression group; (2) participant and companion differences within each group; and (3) sensitivity of the 12-item WHODAS in comparison to the 36-item WHODAS and the Total Functional Capacity (TFC) score from the Unified Huntington's Disease Rating Scale. Participants showed baseline group differences whereas companions showed baseline and longitudinal group differences. Companions reported worse functional decline over time than participants as the disease progresses. The 12-item WHODAS detected longitudinal change better than the 36-item WHODAS and the TFC in the medium progression group. Results suggest the 12-item WHODAS 2.0 can detect baseline and longitudinal differences in prodromal HD and may be useful in HD clinical trials.

U2 - 10.1038/ejhg.2015.11

DO - 10.1038/ejhg.2015.11

M3 - Article

C2 - 25735480

SN - 1018-4813

VL - 23

SP - 1584

EP - 1587

JO - EJHG : European journal of human genetics : the official journal of the European Society of Human Genetics.

JF - EJHG : European journal of human genetics : the official journal of the European Society of Human Genetics.

IS - 11

ER -

Performance of the 12-item WHODAS 2.0 in prodromal Huntington disease

Abstract

Bibliographical note

Access to Document

Fingerprint

Cite this